Medicare Enrolled
Dr. Jagathi Challagalla, M.D.
Medical Oncology · Wichita Falls, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Challagalla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Challagalla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Challagalla
Dr. Jagathi Challagalla is a medical oncology specialist in Wichita Falls, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Challagalla performed 372,508 Medicare services across 9,387 unique beneficiaries.
Between the years covered by Open Payments, Dr. Challagalla received a total of $91,549 from 66 pharmaceutical and/or device companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Challagalla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in TX
$91,549 industry payments
Medicare Practice Summary
Medicare Utilization ↗372,508
Medicare services
Top 1% in TX for medical oncology
9,387
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~18,625 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
167,790 | $0 | $5 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
48,120 | $0 | $2 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
28,806 | $0 | $3 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
23,800 | $2 | $20 |
| Pembrolizumab injection (Keytruda) | 23,500 | $43 | $137 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
21,000 | $0 | $33 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
13,698 | $0 | $13 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
11,200 | $0 | $2 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
3,112 | $8 | $20 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
3,100 | $23 | $181 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,928 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,746 | $8 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
2,665 | $10 | $64 |
| Denosumab injection (Prolia/Xgeva) | 1,620 | $16 | $67 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,485 | $62 | $250 |
| Injection, atropine sulfate, 0.01 mg | 1,360 | $0 | $1 |
| Injection, leucovorin calcium, per 50 mg | 1,189 | $3 | $25 |
| Injection, granisetron hydrochloride, 100 mcg | 1,150 | $0 | $24 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
900 | $2 | $13 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
840 | $80 | $1,348 |
| Iron level test | 749 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
749 | $9 | $35 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
745 | $13 | $60 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
616 | $12 | $108 |
| Anti-nausea injection (Aloxi/palonosetron) | 570 | $1 | $114 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
503 | $98 | $707 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
486 | $46 | $313 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
336 | $19 | $99 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 328 | $3 | $373 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
313 | $10 | $96 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
305 | $94 | $368 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
300 | $7 | $431 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
296 | $6 | $34 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
295 | $4 | $22 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
280 | $6 | $31 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
267 | $45 | $821 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
244 | $169 | $1,067 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
233 | $22 | $157 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
220 | $2 | $300 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
179 | $49 | $344 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
177 | $21 | $161 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
175 | $55 | $211 |
| PSA test (prostate cancer screening) | 162 | $18 | $94 |
| Piflufolastat F-18 diagnostic injection A diagnostic injection of the radioactive tracer piflufolastat F-18 used for imaging. The dose specified is 1 millicurie. |
159 | $590 | $1,677 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
158 | $5 | $31 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
156 | $18 | $114 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 144 | $20 | $128 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
137 | $70 | $70 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
135 | $1 | $7 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
124 | $75 | $372 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 118 | $341 | $1,722 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
116 | $1,101 | $4,802 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
110 | $119 | $565 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 109 | $90 | $657 |
| Intensity-modulated radiation therapy delivery Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session. |
108 | $272 | $2,762 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
101 | $42 | $289 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
96 | $1 | $6 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
94 | $123 | $500 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
91 | $25 | $145 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
88 | $15 | $94 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
82 | $1 | $8 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
78 | $7 | $29 |
| CT scan of neck soft tissue with contrast A computed tomography scan that uses contrast dye to create detailed images of the soft tissues in the neck. |
70 | $48 | $658 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
70 | $2 | $19 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
69 | $14 | $96 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
62 | $34 | $686 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
53 | $76 | $560 |
| Radiation therapy, 3+ areas, 11-19 MeV Delivery of high-energy radiation (11-19 MeV) to three or more separate treatment areas using custom blocking, tangential ports, wedges, rotational beams, and compensators. |
49 | $178 | $700 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 47 | $134 | $3,675 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
42 | $2 | $16 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
40 | $16 | $100 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
40 | $1 | $19 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
33 | $4 | $23 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
32 | $4 | $25 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
29 | $25 | $256 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
29 | $70 | $264 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
28 | $9 | $75 |
| Radiation therapy, 3+ areas, 6-10 MeV Radiation treatment delivered to three or more separate areas using advanced techniques like custom blocking and rotational beams with an energy level of 6-10 MeV. |
27 | $177 | $700 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
19 | $15 | $76 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
16 | $1,104 | $4,929 |
| CT scan of head/brain with and without contrast A CT scan of the head or brain performed using contrast dye both before and after its administration to capture detailed images. |
12 | $64 | $821 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
45.5% high complexity
50.4% medium
4.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$91,549
Total received (2018-2024)
Avg $13,078/year across 7 years
Top 16% in TX for medical oncology
66
Companies
343
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$70,453 (77.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,234 (16.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,862 (6.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,529
2023
$14,940
2022
$11,646
2021
$11,936
2020
$15,740
2019
$8,725
2018
$22,031
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$9,269
Gilead Sciences, Inc.
$9,003
Takeda Pharmaceuticals U.S.A., Inc.
$7,692
BeiGene USA, Inc.
$6,488
Celgene Corporation
$6,226
Janssen Biotech, Inc.
$5,859
Exelixis Inc.
$3,857
AstraZeneca Pharmaceuticals LP
$3,826
Bayer HealthCare Pharmaceuticals Inc.
$3,665
Karyopharm Therapeutics Inc.
$3,647
Fresenius Kabi USA, LLC
$3,175
Seagen Inc.
$3,126
GlaxoSmithKline, LLC.
$2,473
Amgen Inc.
$2,309
Seattle Genetics, Inc.
$2,128
Helsinn Therapeutics (U.S.), Inc.
$1,800
Rigel Pharmaceuticals, Inc.
$1,439
Kite Pharma, Inc.
$1,406
Daiichi Sankyo Inc.
$1,243
GENZYME CORPORATION
$1,200
Aveo Pharmaceuticals, Inc.
$1,050
CTI BioPharma Corp.
$1,018
BeiGene, Ltd.
$975
Novartis Pharmaceuticals Corporation
$947
Adaptive Biotechnologies Corporation
$846
Astellas Pharma US Inc
$794
Janssen Scientific Affairs, LLC
$758
Bayer Healthcare Pharmaceuticals Inc.
$656
EMD Serono, Inc.
$500
Lilly USA, LLC
$495
Pharmacyclics LLC, An AbbVie Company
$446
Incyte Corporation
$375
E.R. Squibb & Sons, L.L.C.
$370
PUMA BIOTECHNOLOGY, INC.
$256
Tempus AI, Inc
$163
Puma Biotechnology, Inc.
$155
Alexion Pharmaceuticals, Inc.
$150
Foundation Medicine, Inc.
$147
Pharmacosmos Therapeutics Inc.
$144
Taiho Oncology, Inc.
$141
Blueprint Medicines Corporation
$123
Clovis Oncology, Inc.
$121
Genentech USA, Inc.
$119
Verastem, Inc.
$117
Epizyme, Inc.,
$96
Merck Sharp & Dohme LLC
$95
Axonics, Inc.
$82
Eisai Inc.
$69
Apellis Pharmaceuticals, Inc.
$57
Regeneron Healthcare Solutions, Inc.
$56
ADC Therapeutics America, Inc.
$46
ABBVIE INC.
$38
Ipsen Biopharmaceuticals, Inc
$36
PharmaEssentia USA Corporation
$34
ImmunoGen, Inc.
$27
Acrotech Biopharma LLC
$24
Pharmacyclics LLC, an AbbVie Company
$23
Sun Pharmaceutical Industries Inc.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Acrotech Biopharma Inc.
$22
AbbVie Inc.
$20
Secura Bio, Inc.
$20
Sobi, Inc
$18
Stemline Therapeutics Inc.
$16
AVEO Pharmaceuticals, Inc.
$15
Kyowa Kirin, Inc.
$15
Top 3 companies account for 28.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · Aliqopa · Axonics · BELEODAQ · BESREMI · BOSULIF · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DAURISMO · DOPTELET · ELIQUIS · ENHERTU · EPKINLY · ERLEADA · EXKIVITY · Elahere · Empaveli · Enhertu · FOTIVDA · Fabhalta · Farydak · GAVRETO · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nubeqa · OJJAARA · OPDIVO · Odomzo · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · Perjeta · Polivy · Pomalyst · Poteligeo · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SOMATULINE DEPOT · SUTENT · Stimufend · Stivarga · TABRECTA · TAGRISSO · TALZENNA · TAZVERIK · TRUSELTIQ · TUKYSA · Tavalisse · Tazverik · Tepmetko · Trodelvy · Ultomiris · VENCLEXTA · VERZENIO · Vanflyta · Vonjo · XPOVIO · XTANDI · Xofigo · Xtandi · Yescarta · ZEJULA · Zydelig · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (77%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $25 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
3
Per 100K population
34.3
County median income
$71,958
Nearest hospital
KELL WEST REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Challagalla is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with consulting-driven industry engagement in the top 16% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Challagalla experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Challagalla performed 167,790 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Challagalla receive payments from pharmaceutical companies?
Yes. Dr. Challagalla received a total of $91,549 from 66 companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Challagalla's costs compare to other medical oncologists in Wichita Falls?
Dr. Challagalla's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Challagalla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Wichita Falls
Browse medical oncologists in Wichita Falls ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology